相关实验视频
Updated: Jul 1, 2026

13:51
The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
15.9K
多酶共定位策略的进展,用于构建微生物细胞工厂
Qi Guo1, Yu-Xin Yang1, Dong-Xun Li1
1School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, 2 Xuelin Road, Qixia District, Nanjing 210023, People's Republic of China.
Biotechnology advances
|September 15, 2024
概括
酶共定位策略通过克服产品合成和细胞生长之间的冲突来增强自然产品生产的细胞工厂. 这提高了生物制造的产量和生产率.
科学领域:
- 生物技术是生物技术.
- 合成生物学 合成生物学
- 代谢工程是代谢工程.
背景情况:
- 由合成生物学驱动的生物制造对生物经济和可持续发展至关重要.
- 细胞工厂是生物制造的核心,使各种自然产品合成成为可能.
- 挑战包括产品形成和细胞生长之间的冲突,导致产量低.
研究的目的:
- 审查酶共定位策略,以在细胞工厂中高效地生产自然产品.
- 为突出生物制造合成生物学方面的进步.
- 解决代谢工程中的挑战,以提高产量.
主要方法:
- 酶共定位策略. 酶共定位策略.
- 基于酶的分类. 基于酶的分类.
- 基于代谢途径的分类.
- 基于合成有机体的分类.
主要成果:
- 酶的共同定位有效地解决了产品合成和细胞生长之间的冲突.
- 分区化策略显著提高了产品标题和整体生产力.
- 审查的方法表明,在天然产品生物制造中提高了效率.
结论:
- 酶共定位是优化细胞工厂的一个关键策略.
- 进一步的研究应该探索将战略与先进技术结合起来.
- 生物制造对可持续发展和经济增长具有重大潜力.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...

